Canada markets close in 2 hours 19 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
46.68-0.71 (-1.50%)
As of 1:39PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 52.10B
Enterprise Value 31.94B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)207.93
Price/Book (mrq)11.55
Enterprise Value/Revenue 3225.51
Enterprise Value/EBITDA 7-38.77

Trading Information

Stock Price History

Beta (5Y Monthly) 3.02
52-Week Change 3207.73%
S&P500 52-Week Change 333.64%
52 Week High 357.20
52 Week Low 314.56
50-Day Moving Average 352.26
200-Day Moving Average 339.22

Share Statistics

Avg Vol (3 month) 3528.85k
Avg Vol (10 day) 3456.65k
Shares Outstanding 546.48M
Implied Shares Outstanding 6N/A
Float 839.41M
% Held by Insiders 14.55%
% Held by Institutions 179.22%
Shares Short (Sep. 29, 2021) 42.98M
Short Ratio (Sep. 29, 2021) 45.95
Short % of Float (Sep. 29, 2021) 46.45%
Short % of Shares Outstanding (Sep. 29, 2021) 46.42%
Shares Short (prior month Aug. 30, 2021) 43.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb. 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb. 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-618.24%

Management Effectiveness

Return on Assets (ttm)-14.29%
Return on Equity (ttm)-31.39%

Income Statement

Revenue (ttm)8.62M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)1,374.60%
Gross Profit (ttm)-35.12M
EBITDA -50.12M
Net Income Avi to Common (ttm)-66.03M
Diluted EPS (ttm)-1.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)164.04M
Total Cash Per Share (mrq)3.53
Total Debt (mrq)2.78M
Total Debt/Equity (mrq)1.52
Current Ratio (mrq)11.57
Book Value Per Share (mrq)4.60

Cash Flow Statement

Operating Cash Flow (ttm)-47.09M
Levered Free Cash Flow (ttm)-23.83M